Ovarian sclerosing stromal tumor in a young woman with ectopic pregnancy: clinical, pathological, and immunohistochemical studies.

Int J Clin Exp Pathol

Department of Clinical Immunology, Institute of Laboratory Medicine, Guangdong Medical College Dongguan 523808, China ; Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics Dongguan 523808, China.

Published: September 2014

In this article, we described an ovarian sclerosing stromal tumor (SST) in a young woman with ectopic pregnancy. It is important to distinguish SST from fibroma, thecoma, and lipoid cell tumors clinically and histologically. Several unique histologic features including pseudolobulation, sclerosis and prominent vascularity are clearly reflected at histopathological findings. The SST cells were immunopositive for CD34, Desmin and SMA, and negative for factor VIII-related antigen, CD31, S-100, ER and PR. The patient's postoperative recovery was smooth and she was discharged after 21 days.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885506PMC

Publication Analysis

Top Keywords

ovarian sclerosing
8
sclerosing stromal
8
stromal tumor
8
young woman
8
woman ectopic
8
ectopic pregnancy
8
tumor young
4
pregnancy clinical
4
clinical pathological
4
pathological immunohistochemical
4

Similar Publications

Introduction: There are two approaches to treating pelvic congestion syndrome (PCS): (i) the keep-it-simple (KIS) approach, which involves embolising only the refluxing vein(s), typically the left ovarian vein (LOV) unless the right ovarian vein (ROV) or left/right internal iliac vein (IIV) tributaries are also refluxing; and (ii) the extensive (EXT) approach, which empirically embolises almost all of the LOV, ROV, and left and right IIV tributaries. The aim of this study is to determine whether the KIS approach can effectively treat PCS while minimising the number of treated veins and coils used, without the need for injecting sclerosing agents into pelvic veins or the use of occlusion balloons.

Methods: This is a single-institution retrospective cohort study.

View Article and Find Full Text PDF

Background: Stathmin, a cytosolic microtubule-destabilizing phosphoprotein involved in the regulation of mitosis, is widely expressed in various malignancies and acts as an adverse prognostic factor. Our research analyzed its immunohistochemical expression on a large cohort of ovarian sex cord-stromal tumors, evaluating its potential utility in differential diagnosis, prognosis, and therapeutic application.

Methods: We examined 390 cases of ovarian sex cord-stromal tumors including 281 adult granulosa cell tumors (AGCT), 5 juvenile granulosa cell tumors (JGCT), 33 Sertoli-Leydig cell tumors (SLCT), 50 fibromas/thecomas (F/T), 11 Leydig cell tumors/steroid cell tumors (LCT/SterCT), 5 sex-cord stromal tumors NOS (SCST-NOS), 3 Sertoli cell tumors (SCT), and 2 sclerosing stromal tumors (ScST).

View Article and Find Full Text PDF
Article Synopsis
  • Ovarian hemangioma is a rare tumor, with about 60 cases reported, but only around 10 investigated using MRI and ultrasound, often found by chance during autopsies or surgeries.
  • A case study details a 51-year-old woman with an asymptomatic ovarian hemangioma, discovered through a raised CA125 level and MRI, which showed a cystic solid mass in the left ovary.
  • The conclusion highlights that the MRI features of ovarian hemangiomas resemble those of liver hemangiomas, underlining the need for awareness of these radiological traits for better diagnosis and treatment.
View Article and Find Full Text PDF

Sclerosing stromal tumors are a rare type of ovarian tumor in the category of sex cord stromal tumors, which arise from the ovarian connective tissue. This report concerns a case of a sclerosing stromal tumor in a 19-year-old nulliparous woman who presented with the chief complaints of menstrual irregularities and dyspareunia. Preoperative imaging revealed a complex right adnexal mass with blood flow and without associated ascites.

View Article and Find Full Text PDF

Ovarian sclerosing stromal tumor mimicking malignancy: case series and literature review.

Arch Gynecol Obstet

August 2024

Division of Gynaecology and Obstetrics, Department of Gynaecology, University Medical Centre Ljubljana, Zaloška 7, 1000, Ljubljana, Slovenia.

Background: Sclerosing stromal tumors (SST) are rare ovarian neoplasms that often appear as solid unilateral tumors of the ovary with no specific clinical or radiological presentation. The definitive treatment is surgical removal.

Case Presentation: Our article presents four cases of female patients with sclerosing stromal ovarian tumor with clinical characteristics mimicking malignant ovarian lesions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!